NVAX
insider transactionsNOVAVAX INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Director
$0
9.5K sh
Own +100%
-
Exercise·M
Director
$0
9.5K sh
Own New
-
Grant·A
EVP, R&D
$0
66.0K sh
Own New
-
Grant·A
EVP, R&D
$0
99.5K sh
Own New
-
Exercise·M
Director
$0
7.9K sh
Own +100%
-
Exercise·M
Director
$0
7.9K sh
Own New
-
Exercise·M
EVP, CFO and Treasurer
$0
12.2K sh
Own New
-
Other·F
EVP, CFO and Treasurer
$58.9K
5.9K sh · $9.98
Own -4%
-
Exercise·M
EVP, CFO and Treasurer
$0
12.2K sh
Own +10%
-
Exercise·M
EVP, Chief Strategy Officer
$0
56.3K sh
Own +100%
-
Other·F
EVP, Chief Strategy Officer
$212.9K
22.4K sh · $9.49
Own -14%
-
Exercise·M
EVP, Chief Strategy Officer
$0
56.3K sh
Own +56%
-
Exercise·M
EVP, CFO and Treasurer
$0
43.2K sh
Own +100%
-
Other·F
EVP, CFO and Treasurer
$197.9K
20.9K sh · $9.49
Own -14%
-
Exercise·M
EVP, CFO and Treasurer
$0
43.2K sh
Own +42%
-
Exercise·M
John C Jacobs KEY
President and CEO
$0
150.2K sh
Own +100%
-
Other·F
John C Jacobs KEY
President and CEO
$657.5K
69.3K sh · $9.49
Own -23%
-
Exercise·M
John C Jacobs KEY
President and CEO
$0
150.2K sh
Own +132%
-
Other·D
EVP, Research & Development
$0
26.7K sh
Own -33%
-
Other·F
EVP, Research & Development
$107.4K
11.3K sh · $9.49
Own -32%
-
Exercise·M
EVP, Research & Development
$0
26.7K sh
Own +325%
-
Exercise·M
EVP, Chief Legal Officer
$0
4.0K sh
Own New
-
Other·F
EVP, Chief Legal Officer
$108.0K
11.4K sh · $9.49
Own -11%
-
Exercise·M
EVP, Chief Legal Officer
$0
37.5K sh
Own +59%
-
Grant·A
EVP, Chief Strategy Officer
$1.6M
177.5K sh · $9.09
Own New
-
Grant·A
EVP, Chief Strategy Officer
$0
118.0K sh
Own New
-
Grant·A
EVP, CFO and Treasurer
$1.8M
194.0K sh · $9.09
Own New
-
Grant·A
EVP, CFO and Treasurer
$0
129.5K sh
Own New
-
Grant·A
John C Jacobs KEY
President and CEO
$5.0M
551.5K sh · $9.09
Own New
-
Grant·A
John C Jacobs KEY
President and CEO
$0
367.5K sh
Own New
-
Grant·A
EVP, Chief Legal Officer
$1.4M
152.0K sh · $9.09
Own New
-
Grant·A
EVP, Chief Legal Officer
$0
101.0K sh
Own New
-
Grant·A
EVP, Research & Development
$1.3M
139.5K sh · $9.09
Own New
-
Grant·A
EVP, Research & Development
$0
93.0K sh
Own +1162%
-
Grant·A
EVP, Chief Strategy Officer
$0
177.5K sh
Own New
-
Grant·A
EVP, CFO and Treasurer
$0
194.0K sh
Own New
-
Grant·A
John C Jacobs KEY
President and CEO
$0
551.5K sh
Own New
-
Grant·A
EVP, Research & Development
$0
139.5K sh
Own New
-
Grant·A
EVP, Chief Legal Officer
$0
152.0K sh
Own New
-
Exercise·M
EVP, Chief Strategy Officer
$0
40.0K sh
Own New
-
Exercise·M
EVP, Chief Strategy Officer
$0
19.6K sh
Own New
-
Other·F
EVP, Chief Strategy Officer
$111.2K
11.0K sh · $10.14
Own -10%
-
Exercise·M
EVP, Chief Strategy Officer
$0
40.0K sh
Own +56%
-
Other·F
EVP, Chief Strategy Officer
$54.5K
5.4K sh · $10.14
Own -7%
-
Exercise·M
EVP, Chief Strategy Officer
$0
19.6K sh
Own +34%
-
Other·D
EVP, CFO and Treasurer
$0
58.7K sh
Own -50%
-
Other·F
EVP, CFO and Treasurer
$287.6K
28.4K sh · $10.14
Own -22%
-
Exercise·M
EVP, CFO and Treasurer
$0
58.7K sh
Own +82%
-
Exercise·M
John C Jacobs KEY
President and CEO
$0
83.3K sh
Own New
-
Other·F
John C Jacobs KEY
President and CEO
$389.9K
38.5K sh · $10.14
Own -15%
-
Exercise·M
John C Jacobs KEY
President and CEO
$0
83.3K sh
Own +46%
-
Exercise·M
EVP, Chief Legal Officer
$0
4.0K sh
Own New
-
Other·F
EVP, Chief Legal Officer
$12.3K
1.2K sh · $10.14
Own -2%
-
Exercise·M
EVP, Chief Legal Officer
$0
4.0K sh
Own +7%
-
Exercise·M
John C Jacobs KEY
President and CEO
$0
83.2K sh
Own New
-
Other·F
John C Jacobs KEY
President and CEO
$358.8K
39.1K sh · $9.17
Own -18%
-
Exercise·M
John C Jacobs KEY
President and CEO
$0
83.2K sh
Own +61%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 25, 2026 | Charles W. Newton | Exercise M | 9.5K | $0 |
| Apr 25, 2026 | Charles W. Newton | Exercise M | 9.5K | $0 |
| Apr 14, 2026 | Robert Edward Walker | Grant A | 66.0K | $0 |
| Apr 14, 2026 | Robert Edward Walker | Grant A | 99.5K | $0 |
| Mar 10, 2026 | John W. Shiver | Exercise M | 7.9K | $0 |
| Mar 10, 2026 | John W. Shiver | Exercise M | 7.9K | $0 |
| Mar 7, 2026 | James Patrick Kelly KEY | Exercise M | 12.2K | $0 |
| Mar 7, 2026 | James Patrick Kelly KEY | Other F | 5.9K | $58.9K |
| Mar 7, 2026 | James Patrick Kelly KEY | Exercise M | 12.2K | $0 |
| Mar 3, 2026 | Elaine O'Hara | Exercise M | 56.3K | $0 |
| Mar 3, 2026 | Elaine O'Hara | Other F | 22.4K | $212.9K |
| Mar 3, 2026 | Elaine O'Hara | Exercise M | 56.3K | $0 |
| Mar 3, 2026 | James Patrick Kelly KEY | Exercise M | 43.2K | $0 |
| Mar 3, 2026 | James Patrick Kelly KEY | Other F | 20.9K | $197.9K |
| Mar 3, 2026 | James Patrick Kelly KEY | Exercise M | 43.2K | $0 |
| Mar 3, 2026 | John C Jacobs KEY | Exercise M | 150.2K | $0 |
| Mar 3, 2026 | John C Jacobs KEY | Other F | 69.3K | $657.5K |
| Mar 3, 2026 | John C Jacobs KEY | Exercise M | 150.2K | $0 |
| Mar 3, 2026 | Ruxandra Draghia-Akli | Other D | 26.7K | $0 |
| Mar 3, 2026 | Ruxandra Draghia-Akli | Other F | 11.3K | $107.4K |
| Mar 3, 2026 | Ruxandra Draghia-Akli | Exercise M | 26.7K | $0 |
| Mar 3, 2026 | Mark J Casey | Exercise M | 4.0K | $0 |
| Mar 3, 2026 | Mark J Casey | Other F | 11.4K | $108.0K |
| Mar 3, 2026 | Mark J Casey | Exercise M | 37.5K | $0 |
| Mar 2, 2026 | Elaine O'Hara | Grant A | 177.5K | $1.6M |
| Mar 2, 2026 | Elaine O'Hara | Grant A | 118.0K | $0 |
| Mar 2, 2026 | James Patrick Kelly KEY | Grant A | 194.0K | $1.8M |
| Mar 2, 2026 | James Patrick Kelly KEY | Grant A | 129.5K | $0 |
| Mar 2, 2026 | John C Jacobs KEY | Grant A | 551.5K | $5.0M |
| Mar 2, 2026 | John C Jacobs KEY | Grant A | 367.5K | $0 |
| Mar 2, 2026 | Mark J Casey | Grant A | 152.0K | $1.4M |
| Mar 2, 2026 | Mark J Casey | Grant A | 101.0K | $0 |
| Mar 2, 2026 | Ruxandra Draghia-Akli | Grant A | 139.5K | $1.3M |
| Mar 2, 2026 | Ruxandra Draghia-Akli | Grant A | 93.0K | $0 |
| Mar 2, 2026 | Elaine O'Hara | Grant A | 177.5K | $0 |
| Mar 2, 2026 | James Patrick Kelly KEY | Grant A | 194.0K | $0 |
| Mar 2, 2026 | John C Jacobs KEY | Grant A | 551.5K | $0 |
| Mar 2, 2026 | Ruxandra Draghia-Akli | Grant A | 139.5K | $0 |
| Mar 2, 2026 | Mark J Casey | Grant A | 152.0K | $0 |
| Mar 1, 2026 | Elaine O'Hara | Exercise M | 40.0K | $0 |
| Mar 1, 2026 | Elaine O'Hara | Exercise M | 19.6K | $0 |
| Mar 1, 2026 | Elaine O'Hara | Other F | 11.0K | $111.2K |
| Mar 1, 2026 | Elaine O'Hara | Exercise M | 40.0K | $0 |
| Mar 1, 2026 | Elaine O'Hara | Other F | 5.4K | $54.5K |
| Mar 1, 2026 | Elaine O'Hara | Exercise M | 19.6K | $0 |
| Mar 1, 2026 | James Patrick Kelly KEY | Other D | 58.7K | $0 |
| Mar 1, 2026 | James Patrick Kelly KEY | Other F | 28.4K | $287.6K |
| Mar 1, 2026 | James Patrick Kelly KEY | Exercise M | 58.7K | $0 |
| Mar 1, 2026 | John C Jacobs KEY | Exercise M | 83.3K | $0 |
| Mar 1, 2026 | John C Jacobs KEY | Other F | 38.5K | $389.9K |
| Mar 1, 2026 | John C Jacobs KEY | Exercise M | 83.3K | $0 |
| Mar 1, 2026 | Mark J Casey | Exercise M | 4.0K | $0 |
| Mar 1, 2026 | Mark J Casey | Other F | 1.2K | $12.3K |
| Mar 1, 2026 | Mark J Casey | Exercise M | 4.0K | $0 |
| Jan 23, 2026 | John C Jacobs KEY | Exercise M | 83.2K | $0 |
| Jan 23, 2026 | John C Jacobs KEY | Other F | 39.1K | $358.8K |
| Jan 23, 2026 | John C Jacobs KEY | Exercise M | 83.2K | $0 |
About NVAX insider trading
This page tracks insider transactions for NOVAVAX INC (NVAX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.